Jong Seung Kim1,2, Sam Hyun Kwon1,2. 1. Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Chonbuk National University, Jeonju, Korea. 2. Research Institute of Clinical Medicine of Chonbuk National University-Biomedical Research Institute, Chonbuk National University Hospital, Jeonju, Korea.
Abstract
OBJECTIVES/HYPOTHESIS: Inverted papilloma (IP) is a rare benign tumor, which is found in the sinonasal area. It is characterized by recurrence, local destruction, and malignant change. Of these, recurrence is a challenging problem to many otolaryngologists. In this study, we evaluated recurrence based on the type of surgical approach using a meta-analysis. STUDY DESIGN: MEDLINE, Embase, and Cochrane database. METHODS: Relevant studies were identified by searching the following databases: MEDLINE, Embase, and Cochrane through February 2016. Random-effects models were used to estimate risk ratio (RR) and 95% confidence interval (CI). The Newcastle-Ottawa scale was used to assess the quality of cohort studies. RESULTS: Our search yielded 14 retrospective cohort studies involving a total of 696 endoscopic approaches and 444 nonendoscopic approaches. The pooled RR for IP recurrence (endoscopic vs. external approach) was 0.56 [95% CI: 0.36-0.85, I2 =48.3%]. A subgroup analysis was also performed. CONCLUSIONS: Surgical management of IP via an endoscopic approach reduces the risk of recurrence compared to an external approach. Although further data are needed, early- stage IP requires endoscopic or endoscopic-assisted surgery to reduce the risk of tumor recurrence. LEVEL OF EVIDENCE: NA Laryngoscope, 127:52-58, 2017.
OBJECTIVES/HYPOTHESIS: Inverted papilloma (IP) is a rare benign tumor, which is found in the sinonasal area. It is characterized by recurrence, local destruction, and malignant change. Of these, recurrence is a challenging problem to many otolaryngologists. In this study, we evaluated recurrence based on the type of surgical approach using a meta-analysis. STUDY DESIGN: MEDLINE, Embase, and Cochrane database. METHODS: Relevant studies were identified by searching the following databases: MEDLINE, Embase, and Cochrane through February 2016. Random-effects models were used to estimate risk ratio (RR) and 95% confidence interval (CI). The Newcastle-Ottawa scale was used to assess the quality of cohort studies. RESULTS: Our search yielded 14 retrospective cohort studies involving a total of 696 endoscopic approaches and 444 nonendoscopic approaches. The pooled RR for IP recurrence (endoscopic vs. external approach) was 0.56 [95% CI: 0.36-0.85, I2 =48.3%]. A subgroup analysis was also performed. CONCLUSIONS: Surgical management of IP via an endoscopic approach reduces the risk of recurrence compared to an external approach. Although further data are needed, early- stage IP requires endoscopic or endoscopic-assisted surgery to reduce the risk of tumor recurrence. LEVEL OF EVIDENCE: NA Laryngoscope, 127:52-58, 2017.
Authors: Joshua Smith; Aditi Kulkarni; Andrew C Birkeland; Jonathan B McHugh; J Chad Brenner Journal: Otolaryngol Head Neck Surg Date: 2018-05-08 Impact factor: 3.497
Authors: Jake J Lee; Lauren T Roland; Jordan J Licata; Hilary L P Orlowski; Pawina Jiramongkolchai; Jay F Piccirillo; Dorina Kallogjeri; Cristine N Klatt-Cromwell; Rebecca D Chernock; John S Schneider Journal: Laryngoscope Date: 2019-05-21 Impact factor: 3.325
Authors: Taylor R Carle; Vivian Wung; Anthony P Heaney; Harvey K Chiu; Jeffrey D Suh; Marvin Bergsneider; Marilene B Wang Journal: J Neurol Surg B Skull Base Date: 2021-05-17
Authors: Jake J Lee; Hilary L P Orlowski; John S Schneider; Lauren T Roland; Rami Eldaya; Pawina Jiramongkolchai; Dorina Kallogjeri; Rebecca D Chernock; Cristine N Klatt-Cromwell Journal: J Neurol Surg B Skull Base Date: 2020-02-20